Metadata
- Name
- 3-month Study of MSDC-0160 Effects on Brain Glucose Utilization, Cognition & Safety in Subjects With Alzheimer's Disease
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT01374438
- Description
- This study will evaluate the effect of 150 mg MSDC-0160 taken daily for 90 days compared to
the effect of placebo on changes in brain glucose utilization using FDG-PET and cognition in
older persons with mild Alzheimer's disease. Safety and tolerability of MSDC-0160 in this
population will also be studied. These results will be used to design larger studies of
MSDC-0160 in persons with mild Alzheimer's disease. - Data or Study Types
- clinical trial
- Keywords
- FDG-PET, brain glucose utilization, cognitive function, Alzheimer's disease
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2011
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT01374438
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT01374438